Cancer52 is proud to share it's Annual Review covering April 2025 to March 2025. As ever it is fantastic to review what was achieved over the year. Read Cancer52 Annual Review 2024-2025

Cancer52 is proud to launch their report ‘Improving diagnosis: Patient and clinician perspectives on increasing early diagnosis in rare and

Cancer52 is pleased to submit their Annual Review for the financial year 2023-2024 to the Charity Commission.